Gabriela Santos, a global market strategist at the firm’s investment arm, said the asset class will benefit from a cyclical recovery in the global economy, buoyed by advances in Covid-19 vaccines
Gabriela Santos, a global market strategist at the firm’s investment arm, said the asset class will benefit from a cyclical recovery in the global economy, buoyed by advances in Covid-19 vaccines